Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tredegar

9.16
+0.21002.35%
Volume:37.32K
Turnover:336.62K
Market Cap:312.81M
PE:-5.45
High:9.16
Open:9.00
Low:8.91
Close:8.95
Loading ...

Long Shortz with TG Metals: Striking gold at Van Uden

Stockheads
·
06 Mar

TG Metals Resumes Trading After New Project Announcement

TIPRANKS
·
06 Mar

TG Metals Ltd. Announces Proposed Securities Issue

TIPRANKS
·
06 Mar

TG Metals Acquires 80% Stake in Van Uden Gold Project

TIPRANKS
·
06 Mar

TG Therapeutics Price Target Maintained With a $55.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Why TG Therapeutics, Inc. (TGTX) Surged On Monday?

Insider Monkey
·
04 Mar

TG Therapeutics Inc (TGTX) Q4 2024 Earnings Call Highlights: Strong U.S. ...

GuruFocus.com
·
04 Mar

Q4 2024 TG Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
04 Mar

TG Therapeutics Reports Strong 2024 Financial Results and Outlook

TIPRANKS
·
04 Mar

TG Therapeutics Soars Nearly 18% as Strong Q4 Results Fuel Growth Optimism

GuruFocus.com
·
04 Mar

TG Therapeutics (NasdaqCM:TGTX) Reports US$108M Revenue For Q4 2024 With Net Income Of US$23M

Simply Wall St.
·
04 Mar

TG Therapeutics' Shares Rise on 4Q Swing to Profit, Outlook Tops Estimates

Dow Jones
·
04 Mar

TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide

Blockhead
·
03 Mar

TG Therapeutics Swings to Quarterly Profit, Targets Higher Revenue in 2025

Dow Jones
·
03 Mar

TG Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
03 Mar

TG Therapeutics Swings to Q4 Net Income, Revenue Rises; 2025 Revenue Guidance Set

MT Newswires Live
·
03 Mar

TG Therapeutics Expects Full Year 2025 Revenue Of Approximately $540M Versus Consensus Of $548.20M, Including Briumvi U.S. Net Product Revenue Of Approximately $525M

Benzinga
·
03 Mar

GUIDANCE: (TGTX) TG Therapeutics Expects Full Year 2025 Global Revenue About $540M, vs. FactSet Est of $534.4M

MT Newswires Live
·
03 Mar

Earnings Flash (TGTX) TG Therapeutics Posts Q4 EPS $0.15, vs. FactSet Est of $0.16

MT Newswires Live
·
03 Mar

TG Therapeutics Q4 2024 GAAP EPS $0.15, Inline, Sales $108.19M Beat $99.95M Estimate

Benzinga
·
03 Mar